Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
08/2002
08/29/2002US20020120145 Inhibiting farnesyl protein transferase.
08/29/2002US20020119961 Bridged piperazine derivatives
08/29/2002CA2440197A1 Synthetic vaccines comprising polyhydroxypolymer carriers
08/29/2002CA2438598A1 Epothilone derivatives for the treatment of refractory tumors
08/29/2002CA2438504A1 Treatment of solid tumours with rapamycin derivatives
08/29/2002CA2434648A1 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
08/28/2002EP1233773A1 Mixture of pomegranate seed oil and juice products
08/28/2002EP1073653B1 Novel 2-heterocyclically substituted dihydropyrimidines
08/28/2002EP0988300B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
08/28/2002CN1089577C Use of novel glass compositions of preparing dental glass pillars and support pillars and method for producing glass pillars
08/27/2002US6441193 Intermediates such as 1-(2-(4-(6-methoxy-3,4-dihydronaphtha-len-1-yl)phenoxy)ethyl)pyrrolidine and compounds such as cis-6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol, hydrobromide salt
08/27/2002US6441179 Intermediates useful for the preparation of antihistaminic piperidine derivatives
08/27/2002US6441036 Treating atherosclerosis and insulin resistance
08/27/2002CA2335440C Chinese herbs extract
08/22/2002WO2002064568A1 Pyridine matrix metalloproteinase inhibitors
08/22/2002WO2002064126A2 Method of treating of demyelinating diseases or conditions
08/22/2002WO2002064082A2 Herbal medication for the improvement of aids patients
08/22/2002WO2002064081A2 Herbal/medication for the improvement of aids patients
08/22/2002CA2438712A1 Method of treating of demyelinating diseases or conditions
08/22/2002CA2434982A1 Pyridine matrix metalloproteinase inhibitors
08/21/2002EP1232745A1 Carrier particles for use in dry powder inhalers
08/21/2002EP1231943A1 Interferon gamma conjugates
08/21/2002CN1365284A Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
08/21/2002CN1364458A Controlled release hydroxy-ketone
08/21/2002CN1364430A Method for storaging acid liquid or semiliquid composition containing kreatin for human consumption
08/21/2002CN1089245C Soy extract, process for its prepn. and pharmaceutical compsn.
08/21/2002CN1089231C Granular compositions
08/20/2002US6436913 Use of estramustine phosphate in the treatment of bone metastasis
08/20/2002US6436385 Trimethylglycine compound
08/20/2002US6436371 Oral composition
08/20/2002CA2266183C Herbal composition for treatment of bronchitis and respiratory disorders with anti cancer properties and process for preparing same
08/20/2002CA2098404C Improved humanized immunoglobulins
08/20/2002CA2063886C Polyethylene protein conjugates
08/20/2002CA2045077C Anti-epileptics
08/20/2002CA2006865C Humanized immunoglobulins and their production and use
08/15/2002WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors
08/15/2002WO2002062302A2 Steroidal derivatives
08/15/2002WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/15/2002WO2002018369A3 Peptidomimetic protease inhibitors
08/15/2002WO2001091763A3 Extracts from spermatophyte plants with antitumor activity
08/15/2002US20020111333 Hypotensive agents; cardiovascular disorders
08/15/2002US20020110608 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
08/15/2002CA2438221A1 Steroidal derivatives
08/14/2002EP1230236A1 Compound with growth hormone releasing properties
08/14/2002EP1229929A2 VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE
08/14/2002EP1229905A2 Transdermal drug delivery devices comprising (r)-(z)-1- azabicyclo[2.2.1]heptan-3-one, o-[3(3-methoxyphenyl)-2-propynyl]oxime
08/14/2002EP1087976B1 Polymorphic clopidogrel hydrogenesulphate form
08/14/2002EP1011625B1 Cleansing compositions
08/14/2002EP0977582B1 Pharmaceutical combined preparations containing erythropoietin and iron preparations
08/14/2002EP0827391B1 Cosmetic composition including an acrylic anionic polymer and an oxyalkylene silicone
08/14/2002CN1089008C In-vivo diagnostic process by near infrared radiation
08/13/2002US6433026 Process for removing bile salts from a patient and alkylated compositions therefor
08/13/2002US6432455 Symptomatic relief of allergic reactions
08/13/2002US6432401 Administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist; use in hair graft procedures, for example
08/13/2002US6432146 Use of a combination of two cationic dyes for the direct dyeing of keratin fibers
08/13/2002CA2328851C Humanized immunoglobulins and their production and use
08/08/2002WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
08/08/2002WO2002060902A1 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
08/08/2002WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
08/08/2002WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
08/08/2002WO2002060391A2 Pharmaceutical composition for the prevention and treatment of scar tissue
08/08/2002WO2002060379A2 Composition comprising extracts of flos lonicerae, fructus forsythiae and radix scutellariae, uses and preparation thereof
08/08/2002WO2002024690A8 Efficient process for the preparation of a factor xa inhibitor
08/08/2002WO2002024145A3 Antiviral substances from plant cuticular and epicuticular material
08/08/2002WO2002014347A3 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
08/08/2002WO2001064182A9 Improvements in or relating to the delivery of oral drugs
08/08/2002US20020107277 Novel method and use
08/08/2002US20020107233 Useful for treating hypocholesterolemia
08/08/2002US20020107225 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia
08/08/2002US20020106743 IL-17 homologous polypeptides and therapeutic uses thereof
08/08/2002US20020106403 Dispersible phospholipid stabilized microparticles
08/08/2002US20020106390 Use of nanodispersions in cosmetic end formulations
08/08/2002US20020106339 Compositions and methods using direct MMP inhibitors for inhibiting photoaging of skin
08/08/2002US20020106328 Contrast agents
08/08/2002CA2672805A1 Pyrimidine derivatives
08/08/2002CA2436551A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
08/08/2002CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
08/08/2002CA2434970A1 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
08/08/2002CA2434281A1 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
08/07/2002EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity
08/07/2002EP1228029A1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
08/07/2002EP1227838A2 Melanoma vaccine and methods of making and using same
08/07/2002EP1227806A1 Pharmaceutical formulation containing tolterodine and its use
08/07/2002EP1109527B1 Cosmetic composition
08/07/2002EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
08/07/2002CN1362964A Novel 8A-and 9A-15-membered lactams
08/07/2002CN1362963A 3-deoxy-desmycosin derivatives and process for their preparation
08/07/2002CN1362960A Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones
08/07/2002CN1362959A C10 carbamoyloxy substituted taxanes as antitumor agents
08/07/2002CN1362958A C7 carbonate substituted taxanes as antitumor agents
08/07/2002CN1362957A C17 heterosubustituted acetate taxanes as antitumor agents
08/07/2002CN1362956A C7 carbamoyloxy substituted taxanes as antitumor agents
08/07/2002CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor
08/07/2002CN1362881A Inflammatory mediation obtained from atractylodes lancea
08/07/2002CN1088580C Aerosol drug formulations
08/06/2002US6429210 Orthorombic polymorph of clopidogrel hydrogen sulfate with improved stability and lower solubility; antithrombotic agent; specific crystal structure and thermodynamic properties
08/06/2002US6429202 Administering complex with phospholipids to prevent atherosclerosis and myocardial or cerebral infarctions; reduces formation of arterial plaques
08/06/2002US6428824 Treating sexual disorders with benzyl isothiocyanate, lepidium sterol component, lepidium fatty acid and a macamide component; cellulose-free
08/06/2002US6428580 Oxidizing mixture containing ascorbic acid, metal compound and oxidizer
08/01/2002WO2002059127A2 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists